Lux-Breast 3; Randomised Phase II Study of Afatinib Alone or in Combination With Vinorelbine Versus Investigator's Choice of Treatment in Patients With HER2 Positive Breast Cancer With Progressive Brain Metastases After Trastuzumab and/or Lapatinib Based Therapy
收藏DataCite Commons2025-11-14 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00003649/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The aim of this study is to investigate the efficacy and safety of afatinib alone or in combination with vinorelbine, as treatment in patients with HER2-overexpressing metastatic breast cancer, who have progressive brain lesions after trastuzumab and/or lapatinib based therapy
提供机构：
Vivli
创建时间：
2019-04-12
